Home > Insider Trading > Filing (0000784199-24-000154)

Filing Details

Accession Number:: 0000784199-24-000154
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2024-03-14 20:36:32
Reporting Period:: 2024-02-23

Accepted Time:: 2024-03-14 20:36:32
Original Submission Date:: 2024-02-28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
784199	Artivion Inc.	AORT	Surgical & Medical Instruments & Apparatus (3841)	592417093

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1849615	S. Marshall Stanton	1655 Roberts Blvd., Nw Kennesaw GA 30144	Svp, Clinical & Md Affair	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-02-23	5,386	$0.00	74,089	No	4	A	Direct
Common Stock	Disposition	2024-02-26	1,576	$20.27	72,513	No	4	S	Direct
Common Stock	Acquisiton	2024-02-23	10,644	$0.00	83,157	No	4	A	Direct
Common Stock	Disposition	2024-02-26	1,431	$20.27	81,726	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.
These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,600 shares were sold, when in fact, 1,576 shares were sold.
As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.
Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.
These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,448 shares were sold, when in fact, 1,431 shares were sold.